If you have injured workers on long-term claims with significant pharmacy spend, those reopened files just became the most urgent items on your book.
Workers' compensation drug costs are surging after years of decline, and the turn is happening fast enough that agents need to act before their next renewals. According to Risk & Insurance, pharmacy costs in workers' comp "have reversed course and are rising sharply across most states" — a direct reversal of the multi-year opioid-driven cost plateau agents had begun to treat as the baseline (Risk & Insurance, May 27, 2026).
Why This Reversal Matters for Your Book Right Now
For the better part of a decade, workers' comp pharmacy spend was a story of success — formulary reforms, PBM oversight, and opioid crackdowns drove per-claim drug costs down in most jurisdictions. That trend is now bending upward again. The Risk & Insurance report notes the reversal is widespread, not isolated to a handful of outlier states, which means it is not a one-jurisdiction problem agents can ignore until a local bureau filing surfaces.
As a national WC product manager, here is what I am watching for on submissions: any account with open claims older than 12 months where pharmacy is still driving medical costs upward. That is the profile that will get flagged in underwriting review, and it is the conversation I would have with the retail producer before the quote goes to the carrier — not after.
Meanwhile, a separate Risk & Insurance analysis on the broader claims landscape underscores that "AI, faster care pathways, and clinical evidence are reshaping industry economics" in both workers' comp and auto claims — suggesting that the tools to monitor pharmacy spend are improving even as the spend itself climbs (Risk & Insurance, May 22, 2026).
What You Should Do in the Next 30 Days
Here is your single concrete action: pull your last 12 months of prescription drug spend by injured worker and flag every claimant whose cumulative pharmacy costs in a single claim exceed $10,000.
That $10,000 threshold is not magic — it is red-flag territory where a claims adjuster should be looping in the carrier's pharmacy benefit manager, checking for duplicate therapies, verifying the prescribing physician's specialty, and confirming the drug protocol matches the jurisdiction's fee schedule and treatment guidelines.
Do this for every open claim on your book, but prioritize these categories:
- Claimsolder than 12 months with active pharmacy — long-duration claims are where drug-cost creep compounds quietly.
- Claims involving independent medical exams (IMEs) or disputed causation — if the claim is litigated, prescribing patterns often widen, and pharmacy costs can double while the legal question lingers.
- Claims in states you know have aggressive fee-schedule enforcement — rising costs in a state with tight controls suggest off-protocol prescribing rather than price inflation, which is a different kind of problem to surface with the underwriter.
Once you have the short-list, do three things with it:
- Send it to your carrier claims contact with a note asking whether the PBM has flagged the same accounts. If the carrier already monitors these claims, confirm what the next clinical review date is.
- Note the upcoming renewal date for each account on the list. A claim with $25,000 in pharmacy costs that is approaching renewal is not a file to close and forget — it is a file to negotiate around or to set the insured expectation for mod impact.
- Document the intervention in your tracking log. If the pharmacy spend comes down before renewal, you have a specific talking point for the underwriter. If it does not, you have records showing you flagged it — which matters for the experience mod discussion on renewal.
The reason this matters now, rather than in six months, is that the reversal is cross-state. It is not confined to one bureau jurisdiction or one carrier's book. That means the claims that were already expensive got more expensive everywhere at once, and the aggregate drag on your book's loss ratio is arriving before the next round of filings.
What This Means for Your Placements
Pharmacy costs do not move the experience mod in isolation — they move it in concert with indemnity and medical. But unlike indemnity, pharmacy spend is often the one component the adjuster can still influence on an open claim. That makes it the highest-leverage line item for an agent to surface before the renewal packet is built.
When this hits agent desks, the question I would ask is simple: do you have the pharmacy spend data for your top 10 open claims, or are you waiting for the loss runs to tell you? If it is the latter, you are already behind.
If you have accounts with open, long-tail claims carrying heavy pharmacy, call this week. Get the spend data into the claims conversation now, while there is still time to affect the outcome. Waiting until the renewal loss runs arrive is waiting too long.
Sources
- Risk & Insurance (2026-05-27)
- Risk & Insurance (2026-05-22)
Tags: workers-comp, pharmacy-costs, claims-management, drug-trends, renewal-prep